| Name | RTIL 13 |
|---|
| Description | RTIL 13 is a potent inhibitor of dynamin GTPase, with an IC50 of 2.3 µM for dynamin I GTPase. RTIL 13 also targets pleckstrin homology lipid binding domain. RTIL 13 can inhibit receptor-mediated and synaptic vesicle endocytosis, with IC50s of 9.3 μM and 7.1 μM, respectively[1][2]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 2.3 µM (dynamin I GTPase)[1] |
| In Vitro | RTIL 13 inhibits receptor-mediated and synaptic vesicle endocytosis, with IC50s of 9.3 μM and 7.1 μM, respectively[2]. |
| References |
| Molecular Formula | C30H55BrN2O3 |
|---|---|
| Molecular Weight | 571.67 |
| Hazard Codes | Xi |
|---|